In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples